71.0
Vistagen Therapeutics, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
Assets
(positive)
Change from FY22 to FY26
millions USD
FY22:
FY23:
17.5
FY24:
121
FY25:
82.1
FY26:
46.9
(positive)
Change from FY22 to FY26
millions USD
FY22:
3.65
FY23:
3.58
FY24:
2.98
FY25:
2.27
FY26:
1.62
Total assets
Change from FY22 to FY26
millions USD
FY22:
74.6
FY23:
21.1
FY24:
124
FY25:
84.3
FY26:
48.6
Liabilities & Equity
(negative)
Change from FY22 to FY26
millions USD
FY22:
5.77
FY23:
4.57
FY24:
5.12
FY25:
12.6
FY26:
12.8
(negative)
Change from FY22 to FY26
millions USD
FY22:
4.16
FY23:
4.44
FY24:
4.24
FY25:
1.34
FY26:
0.25
(positive)
Change from FY22 to FY26
millions USD
FY22:
64.7
FY23:
12.1
FY24:
114
FY25:
70.4
FY26:
35.5
Total liabilities & equity
Change from FY22 to FY26
millions USD
FY22:
74.6
FY23:
21.1
FY24:
124
FY25:
84.3
FY26:
48.6
All amounts in millions USD